Return to study ST002982 main page

MB Sample ID: SA323533

Local Sample ID:R_C48h_EA_23b_1_2
Subject ID:SU003095
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606
Genotype Strain:MDA-MB-231 cells
Gender:Not applicable
Cell Biosource Or Supplier:ATCC (Manassas, VA, USA); ATCC HTB-26
Cell Strain Details:Epithelial breast cancer cells; absence of estrogen and progesterone receptors, HER2 overexpression
Cell Passage Number:Inferior to 10
Cell Counts:5 M

Select appropriate tab below to view additional metadata details:


Treatment:

Treatment ID:TR003104
Treatment Summary:Cells were treated during culture time by adding drugs stock solution to the growth culture medium. Briefly, after seeding, cells were allowed to adhere for 24 h (t = 0 h). After this, the experiment was initiated by adding stock solutions of each drug to achieve the corresponding half of maximal inhibitory effect IC50 values: 1.0 µM cDDP and 7.9 μM Pd2Spm. Phosphate-buffered saline (PBS) was used in control groups. Then, cells were incubated and collected at t = 24 h and t = 48 h, with basis on the population (25.5 ± 0.9 h and 30.6 ± 1.1 h for MDA-MB-231 and MDA-MB-231/R cells, respectively).
Treatment Compound:cDDP or Pd2Spm (PBS for controls)
Treatment Route:Dissolution of drugs stock solutions into the culture medium
Treatment Dose:1.0 µM cDDP and 7.9 μM Pd2Spm
Treatment Dosevolume:5.5 mL
Treatment Doseduration:24 h and 48 h
Treatment Vehicle:Phosphate-buffered saline (PBS)
Cell Media:Dulbecco’s Modified Eagle’s Medium—high-glucose cell growth medium (DMEM-HG)
Cell Envir Cond:Humidified atmosphere of 5% CO2 at 37 ◦C
Cell Harvesting:Tripsinization
Cell Pct Confluence:~ 70 to 80%
  logo